|
CHD8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.688500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.477400E-03 |
| Normal-vs-Stage2 |
4.889700E-02 |
| Normal-vs-Stage3 |
3.315800E-01 |
| Normal-vs-Stage4 |
1.169750E-01 |
| Stage1-vs-Stage2 |
9.732600E-01 |
| Stage1-vs-Stage3 |
5.265200E-01 |
| Stage1-vs-Stage4 |
5.096800E-01 |
| Stage2-vs-Stage3 |
5.967800E-01 |
| Stage2-vs-Stage4 |
5.218200E-01 |
| Stage3-vs-Stage4 |
3.527600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.271800E-02 |
| Normal-vs-AfricanAmerican |
8.846000E-02 |
| Normal-vs-Asian |
1.713600E-01 |
| Caucasian-vs-AfricanAmerican |
8.821000E-01 |
| Caucasian-vs-Asian |
9.017600E-01 |
| AfricanAmerican-vs-Asian |
8.412000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.300400E-03 |
| Normal-vs-Female |
7.786200E-01 |
| Male-vs-Female |
8.437000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.886100E-02 |
| Normal-vs-Extreme_Weight |
2.517600E-03 |
| Normal-vs-Obese |
4.596600E-01 |
| Normal-vs-Extreme_Obese |
7.254200E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.146800E-01 |
| Normal_Weight-vs-Obese |
3.022000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.315400E-01 |
| Extreme_Weight-vs-Obese |
5.041800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.705000E-01 |
| Obese-vs-Extreme_Obese |
1.996790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.670200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.424800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.038000E-04 |
| Normal-vs-Age(81-100Yrs) |
2.357900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.069200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.405700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.018000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.307530E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.618200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.443800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.368200E-02 |
| Normal-VS-Type2 PRCC |
2.754800E-04 |
| Normal-VS-KIRP CIMP |
7.002400E-01 |
| Normal-VS-Unclassified PRCC |
6.275000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.976010E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.132000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.553000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.486400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.682300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.159800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.72329999999344E-05 |
| Normal-vs-N1 |
7.160000E-01 |
| Normal-vs-N2 |
8.220300E-03 |
| N0-vs-N1 |
1.106160E-02 |
| N0-vs-N2 |
5.515600E-01 |
| N1-vs-N2 |
1.465410E-01 |
|
|
